Published in J Otolaryngol on February 01, 1993
Modern management of obstructive salivary diseases. Acta Otorhinolaryngol Ital (2007) 1.37
Unusually large submandibular sialoliths: report of two cases. Eur J Dent (2009) 0.93
Sialoendoscopy: state of the art, challenges and further perspectives. Round Table, 101(st) SIO National Congress, Catania 2014. Acta Otorhinolaryngol Ital (2015) 0.77
Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med (1986) 2.44
Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res (1992) 1.49
Protecting tomorrow's health care professionals against hepatitis B virus today. Arch Intern Med (1991) 1.40
Measuring second-order selection bias in a work site health program. J Occup Med (1994) 1.38
Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res (1998) 1.25
Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res (1995) 1.22
Potential in-hospital modes of transmission of Legionella pneumophila. Demonstration experiments for dissemination by showers, humidifiers, and rinsing of ventilation bag apparatus. Am J Med (1986) 1.15
S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci (2010) 1.14
Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. J Biomed Mater Res (1996) 1.13
Pseudomonas stutzeri bacteremia associated with hemodialysis. Arch Intern Med (1983) 1.10
Heat eradication measures for control of nosocomial Legionnaires' disease. Implementation, education, and cost analysis. Am J Infect Control (1984) 1.00
Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet (1985) 0.97
Isolation of Legionella pneumophila from blood with the BACTEC system: a prospective study yielding positive results. J Clin Microbiol (1985) 0.95
Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (1993) 0.91
Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol (1992) 0.91
Influence of the shock wave application mode on the growth of A-Mel 3 and SSK2 tumors in vivo. Ultrasound Med Biol (1990) 0.90
Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med (1993) 0.90
[Clinical and epidemiological data of patients with malignomas of the head and neck]. Laryngorhinootologie (2002) 0.89
Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand (2000) 0.88
Markers of myocardial ischemia after minimally invasive and conventional coronary operation. Ann Thorac Surg (2000) 0.88
SELF-STERILIZING SURFACES. Science (1942) 0.87
[Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine]. Thorac Cardiovasc Surg (2007) 0.87
Effects of a corporate health promotion program. J Occup Med (1986) 0.87
Engineering of cartilage tissue using bioresorbable polymer fleeces and perfusion culture. Acta Otolaryngol (1995) 0.86
Photodynamic therapy in head and neck surgery. J Photochem Photobiol B (1990) 0.86
Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity. Am J Surg (1996) 0.86
Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. ORL J Otorhinolaryngol Relat Spec (1996) 0.85
Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol (1993) 0.85
The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br J Pharmacol (1995) 0.84
Transmission of Legionella by respiratory equipment and aerosol generating devices. Chest (1992) 0.84
Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol (1995) 0.84
Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol (1996) 0.84
[Reconstruction of a malformed external ear by an endoprosthesis of porous polyethylene with an integrated suction system]. Laryngorhinootologie (1993) 0.83
Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol (1996) 0.83
Ethinylestradiol stimulates a biliary cholesterol-phospholipid cosecretion mechanism in the hamster. Hepatology (1988) 0.83
Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope (1996) 0.83
Disinfection of water distribution systems for legionella: a review of application procedures and methodologies. Infect Control Hosp Epidemiol (1990) 0.83
Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope (1996) 0.83
Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Acta Otolaryngol (1999) 0.82
Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol (1992) 0.82
[Endoscopic controlled laser lithotripsy in the treatment of sialolithiasis]. Laryngorhinootologie (1990) 0.82
[Photodynamic therapy with derivatives from hemotoporphyrines for recurrent laryngeal papillomatosis of the children. Early results]. An Otorrinolaringol Ibero Am (1993) 0.81
Screening for nosocomial legionellosis by culture of the water supply and targeting of high-risk patients for specialized laboratory testing. Am J Infect Control (1991) 0.80
Effect of dietary n-3 versus n-6 polyunsaturated fatty acids on hepatic excretion of cholesterol in the hamster. J Lipid Res (1993) 0.80
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol (1996) 0.80
Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia (2006) 0.80
An improved closed cranial window technique for investigation of blood-brain barrier function and cerebral vasomotor control in the rat. Int J Microcirc Clin Exp (1990) 0.80
[Intra-arterial cisplatin and sequential radiotherapy. Long-term follow-up]. Laryngorhinootologie (1996) 0.80
Effect of growth factors on matrix synthesis by human nasal chondrocytes cultured in monolayer and in agar. Eur Arch Otorhinolaryngol (1996) 0.80
A comparison of class II antigenicity of human tracheal allografts stored in cialit and in merthiolate. Laryngoscope (1990) 0.79
[Measurement of temperature and sound pressure in the inner ear during application of the argon-laser (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1981) 0.79
[Navigation surgery in diseases of the paranasal sinuses]. Laryngorhinootologie (1999) 0.79
Distribution of microflow and oxygen tension in hamster melanoma. Int J Microcirc Clin Exp (1982) 0.79
The lateral cyst of the neck: congenital or acquired? Acta Otolaryngol (1987) 0.78
[Otorhinolaryngologic manifestations in patients infected by the acquired immunodeficiency virus]. Acta Otorrinolaringol Esp (1991) 0.78
[Autologous rib cartilage harvesting: operative procedure and postoperative pain reduction]. Laryngorhinootologie (2000) 0.78
[Benign lymphoepithelial parotid cysts in patients infected with the human immunodeficiency virus]. An Otorrinolaringol Ibero Am (1991) 0.78
Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol (1996) 0.78
Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res (1999) 0.78
Cisplatinum and interstitial laser therapy for advanced head and neck cancer: a preclinical study. Lasers Surg Med (1997) 0.78
Tracheal transplantation: demonstration of HLA class II subregion gene products on human trachea. Acta Otolaryngol (1990) 0.78
[New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation]. Laryngorhinootologie (1993) 0.78
[Importance of increased interstitial fluid pressure in therapy of malignant tumors of the head-neck area]. Laryngorhinootologie (1993) 0.78
Quantitative in vivo measurement of the fluorescent components of Photofrin II. Photochem Photobiol (1987) 0.78
[Photodynamic diagnosis of neoplasms of the mouth cavity after local administration of 5-aminolevulinic acid]. Laryngorhinootologie (1996) 0.78
[Transplantation of in vitro cultured cartilage materials: characterization of matrix synthesis]. Laryngorhinootologie (1997) 0.78
Detection of class II antigens on human nasal cartilage. Am J Otolaryngol (1991) 0.78
[Somatic gene therapy in squamous epithelial carcinomas of the head-neck area]. Laryngorhinootologie (1996) 0.77
[A new system for the classification of ethmoid polyposis. Effect of combined local and systemic steroid therapy]. Laryngorhinootologie (2000) 0.77
[Assessing the quality of the speaking voice after therapy of T1 and T2 vocal cord cancers]. Laryngorhinootologie (1992) 0.77
Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas. Eur Arch Otorhinolaryngol (1997) 0.77
Myocardial surface PO2--an indicator of myocardial tissue oxygenation? Cardiovasc Res (1989) 0.77
A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies. Clin Cancer Res (2001) 0.77
Comparison of the TEMPO+ ear-level speech processor and the cis pro+ body-worn processor in adult MED-EL cochlear implant users. ORL J Otorhinolaryngol Relat Spec (2001) 0.77
[Subcutaneous preservation of an amputated auricle. Morphological changes]. Laryngorhinootologie (2000) 0.77
Relapsing polychondritis: a course over 20 years with cerebral involvement. Arch Otolaryngol Head Neck Surg (2000) 0.77
[Clinical and electron microscopy study of sudden deafness treatment with the 10% HES 200/0.5 and pentoxifylline combination]. Laryngorhinootologie (1995) 0.77
Functional morphology of nasal blood vessels in humans. Acta Otolaryngol (1996) 0.77
Photodynamic laser therapy of basal-cell carcinoma of the lid. Ger J Ophthalmol (1993) 0.77
Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract. Eur Arch Otorhinolaryngol (1993) 0.77
[Microtia: technique for external ear reconstruction with autologous rib cartilage]. Handchir Mikrochir Plast Chir (2001) 0.77
[How I do it. On nomenclature of transplantations in otorhinolaryngology]. Laryngorhinootologie (1991) 0.77
Expression of human intercellular adhesion molecules in middle ear cholesteatoma. Am J Otolaryngol (1994) 0.76
[Photodynamic diagnosis and therapy of neoplasms of the facial skin after topical administration of 5-aminolevulinic acid]. Laryngorhinootologie (1995) 0.76
[On surgery of cartilaginous wry nose]. HNO (1968) 0.76
Immunotype findings in macrophages in aural cholesteatomas. Eur Arch Otorhinolaryngol (1992) 0.76
[Endoscopic and extracorporeal shock wave lithotripsy of salivary calculi]. Laryngorhinootologie (1995) 0.76
High levels of fibronectin in the stroma of aural cholesteatoma. Am J Otolaryngol (1995) 0.75
Gains in life expectancy from medical interventions. N Engl J Med (1998) 0.75
Community-acquired pneumonia caused by Legionella dumoffii in a patient with hairy cell leukemia. Infection (1991) 0.75
Copper-silver ionization: cautious optimism for Legionella disinfection and implications for environmental culturing. Am J Infect Control (1997) 0.75
[Influence of nasal obstruction on sleep-associated breathing disorders]. Laryngorhinootologie (1999) 0.75
The effect of gamma-interferon on HLA class II antigen expression on isolated human nasal chondrocytes. Eur Arch Otorhinolaryngol (1990) 0.75